Key Takeaways

• In the SCALE Obesity and Prediabetes trial (n=3,731), patients on Saxenda lost an average of 18.5 pounds over 56 weeks compared to 6.1 pounds on placebo .
• 63.2% of Saxenda patients lost at least 5% of their body weight, a threshold considered clinically meaningful for reducing obesity-related health risks.
• Results are most pronounced in the first 6 to 9 months of treatment before plateauing as the body reaches a new energy equilibrium.
• Patients who combine Saxenda with structured diet and exercise programs typically outperform clinical trial averages by 20 to 40%.
• Body composition changes (reduced waist circumference, improved visceral fat) often occur even when scale weight changes seem modest.
• The 16-week checkpoint is critical: if you have not lost at least 4% of your body weight by then, Saxenda is unlikely to produce meaningful long-term results .

Overview: What Clinical Trials Tell Us

The most comprehensive Saxenda results come from the SCALE (Satiety and Clinical Adiposity - Liraglutide Evidence) clinical trial program. This series of randomized, double-blind, placebo-controlled studies enrolled over 5,000 participants across multiple countries and remains the gold standard for understanding what Saxenda can realistically accomplish.

Here is a breakdown of the headline numbers from the pivotal SCALE Obesity and Prediabetes trial:

These numbers tell a nuanced story. The average patient lost 18.5 pounds, but the distribution was wide. Some patients lost 30, 40, or even 50+ pounds, while others lost very little. Understanding what separates strong responders from non-responders is key to setting realistic expectations .

Month-by-Month Results Timeline

Weight loss on Saxenda does not happen in a straight line. The trajectory has distinct phases that most patients experience:

Month 1: The Adjustment Period

During the first month, you are still escalating through the five-week dose titration (0.6 mg to 3.0 mg). Weight loss during this phase is typically minimal, ranging from 0 to 4 pounds. Some patients actually see temporary weight gain from water retention or dietary changes made to manage nausea. This is normal and not a sign that the medication is failing.

Month 2 to 3: The Acceleration Phase

Once you reach and stabilize at the full 3.0 mg dose, appetite suppression hits its peak. Most patients report clearly reduced hunger, smaller portion sizes, and diminished food cravings. Weight loss accelerates to roughly 1 to 2 pounds per week. By the end of month 3, cumulative loss of 8 to 15 pounds is typical for responders.

Month 4 to 6: Steady Progress

This is where the transformation becomes visible. Clothing fits differently, waist circumference decreases measurably, and energy levels often improve. The rate of weight loss remains relatively steady at 3 to 6 pounds per month. Total cumulative loss at the 6-month mark averages 15 to 22 pounds for consistent users.

Month 7 to 12: Plateau and Maintenance

Weight loss gradually slows as your body adapts to a lower caloric intake and your resting metabolic rate adjusts downward (a phenomenon called adaptive thermogenesis). By month 9 to 12, many patients reach a weight plateau. This is not failure. It represents a new equilibrium. Total weight loss at one year averages 18 to 20 pounds, with top responders exceeding 30 pounds.

Beyond Year 1

Saxenda's primary role shifts from active weight loss to weight maintenance. In the SCALE Maintenance trial, patients who continued liraglutide after initial weight loss maintained significantly more of their results compared to those who switched to placebo. The placebo group regained an average of 6 pounds while the liraglutide group lost an additional 6 pounds over 56 weeks .

Health Improvements Beyond the Scale

Weight loss is the most visible result, but Saxenda produces a range of metabolic improvements that matter even more for long-term health:

These improvements often begin before significant weight loss is visible on the scale, particularly the metabolic markers like fasting glucose and triglycerides . This is one reason why focusing exclusively on the number on the scale can be misleading.

What Separates Strong Responders from Non-Responders

Not everyone responds to Saxenda equally. Research and clinical experience point to several factors that predict better or worse outcomes:

Factors Associated with Better Results

• Early weight loss. Patients who lose 4% or more of body weight by week 16 are significantly more likely to achieve meaningful long-term results. This is why the FDA recommends a 16-week evaluation point .
• Structured dietary changes. Patients who follow a Saxenda diet plan with adequate protein (1.0 to 1.2 g/kg ideal body weight) and reduced processed food intake see 20 to 40% more weight loss than those who make no dietary changes.
• Regular physical activity. Even moderate exercise (150 minutes per week of walking) enhances results and helps preserve lean muscle mass during weight loss.
• Consistent daily dosing. Adherence matters enormously. Patients who take Saxenda daily as prescribed (not skipping doses to save money or because they feel fine) see better results.
• Physician supervision. Patients in structured programs with regular check-ins, like those offered at Form Blends, are more likely to stay on track through the inevitable plateaus and challenges.

Factors Associated with Weaker Results

• Medication-only approach. Relying entirely on Saxenda without any lifestyle modifications produces less weight loss and higher regain rates.
• Inconsistent dosing. Frequently missing doses or stopping and restarting disrupts the consistent appetite suppression that drives results.
• Underlying endocrine conditions. Untreated hypothyroidism, Cushing syndrome, or certain medications (like corticosteroids) can blunt weight loss response.
• Genetic variation. Emerging research suggests that polymorphisms in the GLP-1 receptor gene may influence individual response to liraglutide .

Body Composition Changes

Scale weight is only part of the picture. Saxenda produces meaningful changes in body composition that affect how you look and feel:

In a DEXA scan sub-study within the SCALE trials, researchers found that approximately 75 to 80% of weight lost on Saxenda was fat mass, with 20 to 25% coming from lean mass . This ratio is roughly comparable to what occurs with diet-only weight loss, though patients who add resistance training can shift the ratio even further in favor of fat loss.

The practical implications are significant. A patient who loses 20 pounds and maintains muscle mass will look very different from someone who loses 20 pounds of mixed fat and muscle. Clothing size changes, visible body shape improvements, and functional fitness gains are all more pronounced when lean mass is preserved.

This is why we strongly recommend resistance training at least 2 to 3 times per week alongside Saxenda treatment. Combined with adequate protein intake (25 to 30 grams per meal), exercise can reduce lean mass loss by 30 to 50% compared to medication and diet alone.

Saxenda Results Compared to Other Treatments

Saxenda delivers roughly triple the weight loss of lifestyle intervention alone, though it produces less dramatic results than newer GLP-1 medications like semaglutide for weight loss or tirzepatide for weight loss. For patients who cannot access or tolerate the newer agents, Saxenda remains a meaningful step up from diet and exercise alone.

Maintaining Results After Saxenda

One of the most important "after" questions is what happens when treatment ends. The data here is sobering but important to understand upfront.

In the SCALE Extension study, patients who stopped liraglutide after achieving weight loss regained approximately two-thirds of their lost weight within 12 months . This is not a failure of willpower. When GLP-1 receptor stimulation stops, appetite returns to pre-treatment levels, and the biological drivers of weight regain reassert themselves.

The best strategies for maintaining results include:

• Continuing Saxenda long-term if it remains effective and tolerable
• Transitioning to a different weight management medication if Saxenda is discontinued
• Maintaining the dietary and exercise habits developed during treatment
• Regular monitoring with your healthcare provider at Form Blends
• Staying aware of early weight regain and intervening quickly

Frequently Asked Questions

How much weight can I realistically lose on Saxenda?

The clinical average is 8% of body weight over one year, but individual results range from minimal (under 3%) to dramatic (over 15%). A 250-pound patient can reasonably expect to lose 15 to 25 pounds with medication, diet, and exercise combined. The strongest predictor of your long-term result is how much you lose in the first 16 weeks.

When will I start seeing results on Saxenda?

Most patients notice appetite changes within the first two weeks. Visible weight loss typically becomes apparent by weeks 6 to 10, after you have been at the full 3.0 mg dose for several weeks. Other people may notice changes in your appearance (slimmer face, looser clothing) before you see dramatic changes on the scale.

Will I lose belly fat specifically on Saxenda?

Saxenda does not target abdominal fat selectively. However, because visceral fat (the metabolically active fat around your organs) is often the first type of fat to respond to caloric restriction, many patients notice waist circumference decreasing early in treatment. The SCALE trials showed an average waist reduction of 3.2 inches, which is significant for cardiometabolic risk reduction.

Do Saxenda results last after stopping the medication?

Without continued treatment or sustained lifestyle changes, most patients regain a substantial portion of lost weight within one to two years. This is consistent with the biology of obesity as a chronic condition. Long-term treatment, either with Saxenda or another medication, is often necessary to maintain results.

How do Saxenda results compare to Wegovy?

The STEP 8 trial directly compared liraglutide 3.0 mg (Saxenda) to semaglutide 2.4 mg (Wegovy) and found that semaglutide produced roughly twice the weight loss: 15.8% versus 6.4% over 68 weeks . However, Saxenda has a longer real-world safety track record and may be preferred in specific clinical situations.

Can I improve my Saxenda results?

Yes. The patients who achieve the best before-and-after transformations typically follow a high-protein diet (1.0 to 1.2 g/kg ideal body weight), engage in regular resistance training, maintain excellent hydration, get 7 to 9 hours of sleep, and work with a supervised medical program. These habits can push your results well above the clinical trial average.

What percentage of people do not respond to Saxenda?

Approximately 37% of patients in the SCALE trials did not achieve the 5% weight loss threshold. If you fall into this category after a fair trial (16+ weeks at 3.0 mg with dietary effort), it does not mean you cannot lose weight. It means Saxenda may not be the right pharmacological tool for you, and your provider can explore alternatives.

See What Saxenda Can Do for You

Results are always personal, but the clinical evidence is clear: Saxenda produces meaningful, measurable weight loss for the majority of patients who use it properly. At Form Blends, we help you maximize your results with physician-guided treatment, personalized nutrition planning, and ongoing support through every phase of your journey. Connect with our team to find out if Saxenda is the right starting point for your goals.